anti-F11R (F11R) Antikörper

anti-F11 Receptor Antikörper (F11R)
Auf finden Sie aktuell 180 F11 Receptor (F11R) Antikörper von 25 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen F11R Proteine (24) und F11R Kits (23) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 251 F11R Produkte verfügbar.
9130004G24, AA638916, CD321, ESTM33, JAM, JAM-1, JAM-A, Jam1, JAMA, Jcam, Jcam1, KAT, Ly106, PAM-1

Meistgesuchte Reaktivitäten zu anti-F11R (F11R) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human F11R Antikörper:

anti-Mouse (Murine) F11R Antikörper:

anti-Rat (Rattus) F11R Antikörper:

Alle verfügbaren anti-F11R Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-F11R Antikörper

  1. Human Monoclonal F11R Primary Antibody für WB - ABIN395554 : Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010 (PubMed)
    Zeige alle 5 Referenzen für 395554

  2. Human Polyclonal F11R Primary Antibody für FACS, IHC (p) - ABIN1106270 : Ostermann, Fraemohs, Baltus, Schober, Lietz, Zernecke, Liehn, Weber: Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. in Arteriosclerosis, thrombosis, and vascular biology 2005 (PubMed)
    Zeige alle 4 Referenzen für 1106270

  3. Human Polyclonal F11R Primary Antibody für FACS, IHC (p) - ABIN1106267 : Fraemohs, Koenen, Ostermann, Heinemann, Weber: The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. in Journal of immunology (Baltimore, Md. : 1950) 2004 (PubMed)
    Zeige alle 4 Referenzen für 1106267

  4. Human Monoclonal F11R Primary Antibody für IHC (fro), FACS - ABIN1106266 : Luo, Zhuo, Fukuhara, Rizzolo: Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line. in Investigative ophthalmology & visual science 2006 (PubMed)
    Zeige alle 4 Referenzen für 1106266

  5. Human Monoclonal F11R Primary Antibody für IHC (fro), FACS - ABIN1106269 : Bazzoni, Martinez-Estrada, Orsenigo, Cordenonsi, Citi, Dejana: Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. in The Journal of biological chemistry 2000 (PubMed)
    Zeige alle 4 Referenzen für 1106269

  6. Mouse (Murine) Monoclonal F11R Primary Antibody für FACS, IHC (fro) - ABIN120283 : Malergue, Galland, Martin, Mansuelle, Aurrand-Lions, Naquet: A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. in Molecular immunology 1999 (PubMed)
    Zeige alle 3 Referenzen für 120283

  7. Human Monoclonal F11R Primary Antibody für FACS, IP - ABIN320125 : Kornecki, Walkowiak, Naik, Ehrlich: Activation of human platelets by a stimulatory monoclonal antibody. in The Journal of biological chemistry 1990 (PubMed)

  8. Human Monoclonal F11R Primary Antibody für FACS - ABIN4897130 : Gatault, Delbeke, Driss, Sarazin, Dendooven, Kahn, Lefèvre, Capron: IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1. in Journal of immunology (Baltimore, Md. : 1950) 2015 (PubMed)

Weitere Antikörper gegen F11R Interaktionspartner

Human F11 Receptor (F11R) Interaktionspartner

  1. We have shown that tension on JAM-A activates RhoA (zeige RHOA Antikörper) to control cell stiffness. Phosphorylation of JAM-A at S284 is required for activation of RhoA (zeige RHOA Antikörper) and increased cell stiffness in response to tension on the protein

  2. Using patient-derived glioblastoma cancer stem cells, we confirmed that JAM-A is suppressed by miR (zeige MLXIP Antikörper)-145

  3. Screening of a library of human cell surface membrane proteins showed that the Hom-1 vesivirus could utilize human junctional adhesion molecule 1 as a receptor to enter cells and initiate replication.

  4. Our results showed that APOC3 (zeige APOC3 Antikörper) was closely associated with the inflammatory process in ECs, and that this process was characterized by the increased expression of TNF-alpha (zeige TNF Antikörper). Inflammatory processes further disrupted the tight junctions (TJs) between HUVECs by causing increased expression of JAM-1.

  5. High expression of junctional adhesion molecule-A and EphB2 (zeige EPHB2 Antikörper) can predict poor overall survival and high mortality rate, and EphB2 (zeige EPHB2 Antikörper) is an independent prognostic biomarker in lung adenocarcinoma patients.

  6. JAM-A is one of the malignancy markers of HNSCC as well as beta-catenin (zeige CTNNB1 Antikörper) in histopathology, and the plasma-soluble JAM-A may contribute to a serum diagnosis of HNSCC. JAM-A is a promising molecular target for diagnosis and therapy in HNSCC.

  7. F11R mrna expression was higher in rheumatoid arthritis patients, but promoter polymorphisms did not appear to be related to disease susceptibility.

  8. Data indicate that junctional adhesion molecule-A (JAM-A) is overexpressed in multiple myeloma (MM) cells and regulates reovirus sensitivity in MM.

  9. JAM-A regulates the planar orientation of the mitotic spindle during epithelial morphogenesis. It triggers transient activation of Cdc42 and PI3K, generates a gradient of PtdIns(3,4,5)P3 at the cortex and regulates the formation of the actin cytoskeleton.

  10. Data indicate that junctional adhesion molecule A (JAM-A) is a potential target of microRNA-495 {miR (zeige MLXIP Antikörper)-495) in breast cancer cells.

Mouse (Murine) F11 Receptor (F11R) Interaktionspartner

  1. Soluble JAM-A secreted from cardiac progenitor cells reduces infiltration of neutrophils after myocardial infarction and ameliorates tissue damage through prevention of excess inflammation.

  2. JAM-A up-regulation can increase the proliferation, cytokine secretion and wound-homing ability of MSCs, thus accelerating the repair rate of full-thickness skin defects

  3. Endothelial JAM-A but not hematopoietic JAM-A facilitates reovirus T1L (zeige CERS6 Antikörper) bloodstream entry and egress.

  4. Deletion of JAM-A causes a gain-of-function in platelets, with lower activation thresholds and increased inflammatory activities. This leads to an increase of plaque formation, particularly in early stages of the disease.

  5. The F11r gene is directly regulated by retinoic acid in the embryonic mesoderm.

  6. Redistribution of JAM-A in endothelial cells after stimulation with pro-atherogenic oxidized lipoproteins results in increased transmigration of mononuclear cells.

  7. JAM-A has a prominent role in regulating leukocyte infiltration after brain I/R injury and could be a new target in limiting post-ischemic inflammation.

  8. JAM-A regulates epithelial permeability via association with ZO-2 (zeige TJP2 Antikörper), afadin (zeige MLLT4 Antikörper), and PDZ-GEF1 (zeige RAPGEF2 Antikörper) to activate Rap2c (zeige RAP2C Antikörper) and control contraction of the apical cytoskeleton.

  9. Cancer stem cells selectively express JAM-A, which regulates self-renewal.

  10. These studies establish F11R as a novel monocyte prognostic marker for GBM critical for defining a subpopulation of stromal cells for future potential therapeutic intervention.

F11R Antigen-Profil

Beschreibung des Gens

Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. The protein encoded by this immunoglobulin superfamily gene member is an important regulator of tight junction assembly in epithelia. In addition, the encoded protein can act as (1) a receptor for reovirus, (2) a ligand for the integrin LFA1, involved in leukocyte transmigration, and (3) a platelet receptor. Multiple 5' alternatively spliced variants, encoding the same protein, have been identified but their biological validity has not been established.

Alternative names and synonyms associated with F11R

  • F11 receptor (F11R) Antikörper
  • F11 receptor (F11r) Antikörper
  • 9130004G24 Antikörper
  • AA638916 Antikörper
  • CD321 Antikörper
  • ESTM33 Antikörper
  • JAM Antikörper
  • JAM-1 Antikörper
  • JAM-A Antikörper
  • Jam1 Antikörper
  • JAMA Antikörper
  • Jcam Antikörper
  • Jcam1 Antikörper
  • KAT Antikörper
  • Ly106 Antikörper
  • PAM-1 Antikörper

Bezeichner auf Proteinebene für anti-F11 Receptor (F11R) Antikörper

junctional adhesion molecule 1 , junctional adhesion molecule A , platelet F11 receptor , platelet adhesion molecule 1 , BV11 antigen , F11 receptor/F11R , junction cell adhesion molecule A , junction cell adhesion molecule1 , JAM-1 , JAM-A

50848 Homo sapiens
16456 Mus musculus
116479 Rattus norvegicus
281258 Bos taurus
653015 Felis catus
Ausgewählte Anbieter für anti-F11R (F11R) Antikörper
Haben Sie etwas anderes gesucht?